Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDRallybio Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 1 | -$1.20 | -$1.20 | -$1.20 |
| Q2 2026 | 1 | -$1.28 | -$1.28 | -$1.28 |
| Q3 2026 | 1 | -$1.44 | -$1.44 | -$1.44 |
| Q4 2026 | 1 | -$1.60 | -$1.60 | -$1.60 |
Rallybio Corp Earnings Date And Information
Rallybio Corp last posted its earnings results on Thursday, August 6th, 2026. The company reported $-1.09 earnings per share for the quarter, topping analysts' consensus estimates of $-1.28 by $0.19. The company had revenue of 0 for the quarter and had revenue of 858.00 K for the year. Rallybio Corp has generated $-2 earnings per share over the last year ($-1.59 diluted earnings per share) and currently has a price-to-earnings ratio of 2.13. Rallybio Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Rallybio Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 08/06/2026 | Q2 2026 | -$1.28 | $7.66 | 8.94 | $0 | $0 |
| 05/13/2026 | Q1 2026 | -$1.20 | -$1.46 | -0.26 | $212.00 K | $212.00 K |
| 03/16/2026 | Q4 2025 | N/A | -$1.11 | N/A | $100.00 K | $222.00 K |
| 11/06/2025 | Q3 2025 | -$1.71 | $2.84 | 4.55 | $66.67 K | $212.00 K |
| 08/07/2025 | Q2 2025 | -$1.96 | -$1.76 | 0.2 | $13.33 K | $212.00 K |
| 05/08/2025 | Q1 2025 | -$1.68 | -$1.68 | 0 | $13.33 K | $212.00 K |
| 03/13/2025 | Q4 2024 | -$2.16 | -$2.00 | 0.16 | $149.50 K | $38.00 K |
| 11/07/2024 | Q3 2024 | -$2.82 | -$2.08 | 0.74 | $75.00 K | $299.00 K |
| 08/08/2024 | Q2 2024 | -$2.99 | -$2.96 | 0.03 | $166.67 K | $299.00 K |
| 05/09/2024 | Q1 2024 | -$2.99 | -$3.76 | -0.77 | N/A | $0 |
| 03/12/2024 | Q4 2023 | -$3.52 | -$4.00 | -0.48 | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.51 | -$3.60 | -3.09 | N/A | $0 |
| 08/08/2023 | Q2 2023 | -$0.48 | -$3.68 | -3.2 | N/A | $0 |
| 05/09/2023 | Q1 2023 | -$0.49 | -$3.44 | -2.95 | N/A | $0 |
| 03/06/2023 | Q4 2022 | -$0.63 | -$3.68 | -3.05 | N/A | $0 |
| 11/07/2022 | Q3 2022 | -$0.54 | -$4.80 | -4.26 | N/A | $0 |
| 08/08/2022 | Q2 2022 | -$0.60 | -$4.56 | -3.97 | N/A | $0 |
| 05/10/2022 | Q1 2022 | -$0.45 | -$3.84 | -3.39 | N/A | $0 |
| 03/15/2022 | Q4 2021 | -$0.39 | -$3.36 | -2.97 | N/A | $0 |
| 11/10/2021 | Q3 2021 | -$7.12 | -$2.96 | 4.16 | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Rallybio Corp Earnings: FAQ's
In the previous quarter, Rallybio Corp (:RLYB) reported $-1.09 earnings per share (EPS) to beat the analysts' consensus estimate of $-1.28 by $0.19.
The conference call for Rallybio Corp's latest earnings report can be listened to online.
The conference call transcript for Rallybio Corp's latest earnings report can be read online.
Rallybio Corp (:RLYB) has a recorded annual revenue of $858.00 K.
Rallybio Corp (:RLYB) has a recorded net income of $-8,978,000.Rallybio Corp has generated $-1.59 earnings per share over the last four quarters.
Rallybio Corp (:RLYB) has a price-to-earnings ratio of 2.13 and price/earnings-to-growth ratio is 0.